<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It has been reported that thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), <z:chebi fb="0" ids="17748">thymidine</z:chebi> phosphorylase (TP), and excision repair cross-complementing-1 (ERCC-1) were useful markers to predict the efficacy of anti <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> agents including <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> (5-FU) and <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> for unresectable advanced <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we analyzed the relationship between the expression of these enzymes and the clinical significance in 49 Stage IV <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients who received mFOLFOX6 as a first-line treatment and evaluated the usefulness of these enzymes for predicting the efficacy of mFOLFOX6 </plain></SENT>
<SENT sid="2" pm="."><plain>There was no relationship between the expression of each enzyme and response rate </plain></SENT>
<SENT sid="3" pm="."><plain>The progression-free survival of the patients with low TP expression was significantly longer than that of the patients with high TP expression( p&lt;0.01) </plain></SENT>
<SENT sid="4" pm="."><plain>In the analysis of overall survival, the patients with low TP or low DPD expression were better than that with high TP expression or high DPD expression (p=0 </plain></SENT>
<SENT sid="5" pm="."><plain>04, p=0 </plain></SENT>
<SENT sid="6" pm="."><plain>04, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>Our results indicated that TP and DPD expression would be a useful marker to predict the efficacy of mFOLFOX6 in the patients with unresectable <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>